Literature DB >> 25906753

Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies.

Christopher F Spurney1, Francis M McCaffrey2, Avital Cnaan3, Lauren P Morgenroth3, Sunil J Ghelani3, Heather Gordish-Dressman3, Adrienne Arrieta3, Anne M Connolly4, Timothy E Lotze5, Craig M McDonald6, Robert T Leshner7, Paula R Clemens8.   

Abstract

BACKGROUND: Cardiac disease is a major cause of death in patients with muscular dystrophies. The use of feasible and reproducible echocardiographic measures of cardiac function is critical to advance the field of therapeutics for dystrophic cardiomyopathy.
METHODS: Participants aged 8 to 18 years with genetically confirmed Duchenne muscular dystrophy (DMD), Becker muscular dystrophy, or limb-girdle muscular dystrophy were enrolled at five centers, and standardized echocardiographic examinations were performed. Measures of systolic and diastolic function and speckle-tracking echocardiography-derived cardiac strain were reviewed independently by two central readers. Furthermore, echocardiographic measures from participants with DMD were compared with those from retrospective age-matched control subjects from a single site to assess measures of myocardial function.
RESULTS: Forty-eight participants (mean age, 13.3 ± 2.7 years) were enrolled. Shortening fraction had a greater interobserver correlation (intraclass correlation coefficient [ICC] = 0.63) compared with ejection fraction (ICC = 0.49). One reader could measure ejection fraction in only 53% of participants. Myocardial performance index measured by pulse-wave Doppler and Doppler tissue imaging showed similar ICCs (0.55 and 0.54). Speckle-tracking echocardiography showed a high ICC (0.96). Focusing on participants with DMD (n = 33), significantly increased mitral A-wave velocities, lower E/A ratios, and lower Doppler tissue imaging mitral lateral E' velocities were observed compared with age-matched control subjects. Speckle-tracking echocardiography demonstrated subclinical myocardial dysfunction with decreased average circumferential and longitudinal strain in three distinct subgroups: participants with DMD with normal shortening fractions, participants with DMD aged < 13 years, and participants with DMD with myocardial performance index scores < 0.40 compared with control subjects.
CONCLUSIONS: In a muscular dystrophy cohort, assessment of cardiac function is feasible and reproducible using shortening fraction, diastolic measures, and myocardial performance index. Cardiac strain measures identified early myocardial disease in patients with DMD.
Copyright © 2015 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac strain; Cardiomyopathy; Echocardiography; Muscular dystrophy

Mesh:

Year:  2015        PMID: 25906753      PMCID: PMC4526320          DOI: 10.1016/j.echo.2015.03.003

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  39 in total

1.  Occult left ventricular dysfunction diagnosed by myocardial performance index in patients with limb girdle muscle dystrophy: A case control study.

Authors:  Rajashekar R Gurrala; Venkata Mb Alla; Wilbert S Aronow; Jai S Shankar; Meena K Angamutta; Krishna Lanka; Sundaram Challa; Chandra K Nair
Journal:  Int J Angiol       Date:  2007

2.  Steroid therapy and cardiac function in Duchenne muscular dystrophy.

Authors:  L W Markham; R L Spicer; P R Khoury; B L Wong; K D Mathews; L H Cripe
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

Review 3.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

4.  Correlation of heart rate and cardiac dysfunction in Duchenne muscular dystrophy.

Authors:  Tamara O Thomas; Thomas M Morgan; William B Burnette; Larry W Markham
Journal:  Pediatr Cardiol       Date:  2012-03-21       Impact factor: 1.655

5.  Two-dimensional speckle tracking imaging detects impaired myocardial performance in children with septic shock, not recognized by conventional echocardiography.

Authors:  Sonali Basu; Lowell H Frank; Kimberly E Fenton; Craig A Sable; Richard J Levy; John T Berger
Journal:  Pediatr Crit Care Med       Date:  2012-05       Impact factor: 3.624

6.  Outcomes of cardiac involvement in patients with late-stage Duchenne muscular dystrophy under management in the pulmonary rehabilitation center of a tertiary referral hospital.

Authors:  Sung Woo Kwon; Seong-Woong Kang; Jong-Youn Kim; Eui-Young Choi; Young Won Yoon; Yoo Mi Park; Dae Won Ma; Hyemoon Chung; Hyuck Moon Kwon; Se-Joong Rim
Journal:  Cardiology       Date:  2012-04-12       Impact factor: 1.869

7.  Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy.

Authors:  Jill E Mayhew; Julaine M Florence; Thomas P Mayhew; Erik K Henricson; Robert T Leshner; Robert J McCarter; Diana M Escolar
Journal:  Muscle Nerve       Date:  2007-01       Impact factor: 3.217

8.  Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy.

Authors:  Yiu-fai Cheung; Wen-jing Hong; Godfrey C F Chan; Sophia J Wong; Shau-yin Ha
Journal:  Heart       Date:  2010-05-29       Impact factor: 5.994

9.  Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy.

Authors:  Larry W Markham; Kathi Kinnett; Brenda L Wong; D Woodrow Benson; Linda H Cripe
Journal:  Neuromuscul Disord       Date:  2008-04-23       Impact factor: 4.296

10.  Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy.

Authors:  Hitoko Ogata; Yuka Ishikawa; Yukitoshi Ishikawa; Ryoji Minami
Journal:  J Cardiol       Date:  2008-10-23       Impact factor: 3.159

View more
  22 in total

1.  Myocardial Strain Using Cardiac MR Feature Tracking and Speckle Tracking Echocardiography in Duchenne Muscular Dystrophy Patients.

Authors:  Bryan Siegel; Laura Olivieri; Heather Gordish-Dressman; Christopher F Spurney
Journal:  Pediatr Cardiol       Date:  2017-11-29       Impact factor: 1.655

2.  Interleukin 1 Receptor-Like 1 Protein (ST2) is a Potential Biomarker for Cardiomyopathy in Duchenne Muscular Dystrophy.

Authors:  Julia Anderson; Haeri Seol; Heather Gordish-Dressman; Yetrib Hathout; Christopher F Spurney
Journal:  Pediatr Cardiol       Date:  2017-08-18       Impact factor: 1.655

3.  Comparison of left ventricular function assessment between echocardiography and MRI in Duchenne muscular dystrophy.

Authors:  Sujatha Buddhe; Mark Lewin; Aaron Olson; Mark Ferguson; Brian D Soriano
Journal:  Pediatr Radiol       Date:  2016-05-12

4.  Troponin I Levels Correlate with Cardiac MR LGE and Native T1 Values in Duchenne Muscular Dystrophy Cardiomyopathy and Identify Early Disease Progression.

Authors:  Sonia Voleti; Laura Olivieri; Karin Hamann; Heather Gordish-Dressman; Christopher Spurney
Journal:  Pediatr Cardiol       Date:  2020-05-31       Impact factor: 1.655

Review 5.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 6.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

7.  The Use of Speckle Tracking Echocardiography for Early Detection of Myocardial Dysfunction in Patients with Duchenne Muscular Dystrophy.

Authors:  Anas Taqatqa; John Bokowski; Maytham Al-Kubaisi; Ahmad Khalil; Carlos Miranda; Hamad Alaksham; Ibtihaj Fughhi; Damien Kenny; Karim A Diab
Journal:  Pediatr Cardiol       Date:  2016-07-25       Impact factor: 1.655

8.  The Correlation of Skeletal and Cardiac Muscle Dysfunction in Duchenne Muscular Dystrophy.

Authors:  Andrew D Posner; Jonathan H Soslow; W Bryan Burnette; Aihua Bian; Ayumi Shintani; Douglas B Sawyer; Larry W Markham
Journal:  J Neuromuscul Dis       Date:  2016-03-03

9.  Reduced Myocardial Reserve in Young X-Linked Muscular Dystrophy Mice Diagnosed by Two-Dimensional Strain Analysis Combined with Stress Echocardiography.

Authors:  Zhenzhou Li; Ying Li; Li Zhang; Xiaoying Zhang; Rebecca Sullivan; Xiaojie Ai; Christopher Szeto; Angela Cai; Longjian Liu; Weidong Xiao; Quanshui Li; Shuping Ge; Xiongwen Chen
Journal:  J Am Soc Echocardiogr       Date:  2017-05-13       Impact factor: 5.251

10.  Evaluation of Echocardiographic Measures of Left Ventricular Function in Patients with Duchenne Muscular Dystrophy: Assessment of Reproducibility and Comparison to Cardiac Magnetic Resonance Imaging.

Authors:  Jonathan H Soslow; Meng Xu; James C Slaughter; Michael Stanley; Kimberly Crum; Larry W Markham; David A Parra
Journal:  J Am Soc Echocardiogr       Date:  2016-08-17       Impact factor: 5.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.